Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Kipniss, Nathan H ^a   Dingal, P C Dave P ^a   Abbott, Timothy R ^a   Gao, Yuchen ^b   Wang, Haifeng ^a   Dominguez, Antonia A ^a   Labanieh, Louai ^a   Qi, Lei S ^a,b  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; FATTY ACID; G PROTEIN COUPLED RECEPTOR; HORMONE; LIGAND; MITOGENIC AGENT;

BIOENGINEERING; CELLS AND CELL COMPONENTS; EQUIPMENT; EUKARYOTE; GENE; GENE EXPRESSION; GENOME; HORMONE; LIGAND; MODELING; PROTEIN;

ARTICLE; CELL ENGINEERING; CELL FUNCTION; CONTROLLED STUDY; CRISPR-CAS9 SYSTEM; EMBRYO; GENE EXPRESSION; GENETIC REGULATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; HEK293 CELL LINE; PROCEDURES; THEORETICAL MODEL;

EUKARYOTA;

CELL ENGINEERING; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; HEK293 CELLS; HUMANS; LIGANDS; MODELS, THEORETICAL; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85038636365     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-02075-1     Document Type: Article

References (43)

1. Lim, W. A. Designing customized cell signalling circuits. Nat. Rev. Mol. Cell. Biol. 11, 393-403 (2010).
2. Katritch, V., Cherezov, V. & Stevens, R. C. Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol. Sci. 33, 17-27 (2012).
3. Rosenbaum, D. M., Rasmussen, S. G. & Kobilka, B. K. The structure and function of G-protein-coupled receptors. Nature 459, 356-363 (2009).
4. Wacker, D., Stevens, R. C. & Roth, B. L. How ligands illuminate GPCR molecular pharmacology. Cell 170, 414-427 (2017).
5. Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. & Roth, B. L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 104, 5163-5168 (2007).
6. Vardy, E. et al. A New DREADD facilitates the multiplexed chemogenetic interrogation of behavior. Neuron 86, 936-946 (2015).
7. Barnea, G. et al. The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105, 64-69 (2008).
8. Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362-369 (2015).
9. Jinek, M. et al. RNA-programmed genome editing in human cells. Elife 2, e00471 (2013).
10. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
11. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
12. Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442-451 (2013).
13. Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833-838 (2013).
14. Zalatan, J. G. et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160, 339-350 (2015).
15. Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583-588 (2015).
16. Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510-517 (2015).
17. Thakore, P. I. et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143-1149 (2015).
18. Amabile, A. et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167, 219 (2016).
19. Ferry, Q. R., Lyutova, R. & Fulga, T. A. Rational design of inducible CRISPR guide RNAs for de novo assembly of transcriptional programs. Nat. Commun. 8, 14633 (2017).
20. Hirosawa, M. et al. Cell-type-specific genome editing with a microRNAresponsive CRISPR-Cas9 switch. Nucleic Acids Res. 45, e118 (2017).
21. Tang, W., Hu, J. H. & Liu, D. R. Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation. Nat. Commun. 8, 15939 (2017).
22. Liu, Y. et al. Directing cellular information flow via CRISPR signal conductors. Nat. Methods 13, 938-944 (2016).
23. Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326-328 (2015).
24. Lauffenburger, D. A. & Linderman, J. J. Receptors: Models for Binding, Trafficking, and Signaling. (Oxford University Press, 1996) New York, USA.
25. Kapust, R. B., Tozser, J., Copeland, T. D. & Waugh, D. S. The P1' specificity of tobacco etch virus protease. Biochem. Biophys. Res. Commun. 294, 949-955 (2002).
26. Gao, Y. et al. Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. Nat. Methods 13, 1043-1049 (2016).
27. Oakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G. & Barak, L. S. Differential affinities of visual arrestin, betaarrestin1, and beta arrestin2 for G proteincoupled receptors delineate two major classes of receptors. J. Biol. Chem. 275, 17201-17210 (2000).
28. Sainz, E., Akeson, M., Mantey, S. A., Jensen, R. T. & Battey, J. F. Four amino acid residues are critical for high affinity binding of neuromedin B to the neuromedin B receptor. J. Biol. Chem. 273, 15927-15932 (1998).
29. Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186-U198 (2015).
30. Zetsche, B. et al. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat. Biotechnol. 35, 31-34 (2017).
31. Dominguez, A. A., Lim, W. A. & Qi, L. S. Beyond editing: repurposing CRISPRCas9 for precision genome regulation and interrogation. Nat. Rev. Mol. Cell. Biol. 17, 5-15 (2016).
32. Baeumler, T. A., Ahmed, A. A. & Fulga, T. A. Engineering synthetic signaling pathways with programmable dCas9-Based chimeric receptors. Cell. Rep. 20, 2639-2653 (2017).
33. Langenhan, T. et al. Model organisms in G protein-coupled receptor research. Mol. Pharmacol. 88, 596-603 (2015).
34. Wise, A., Jupe, S. C. & Rees, S. The identification of ligands at orphan G-protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44, 43-66 (2004).
35. Morsut, L. et al. Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell 164, 780-791 (2016).
36. Schwarz, K. A., Daringer, N. M., Dolberg, T. B. & Leonard, J. N. Rewiring human cellular input-output using modular extracellular sensors. Nat. Chem. Biol. 13, 202-209 (2017).
37. Davila, M. L. et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci. Transl. Med. 6, 224ra225 (2014).
38. Mills, G. B. & Moolenaar, W. H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591 (2003).
39. Congreve, M. & Marshall, F. The impact of GPCR structures on pharmacology and structure-based drug design. Br. J. Pharmacol. 159, 986-996 (2010).
40. Chavez, A. et al. Comparison of Cas9 activators in multiple species. Nat. Methods 13, 563-567 (2016).
41. Isberg, V. et al. GPCRdb: an information system for G protein-coupled receptors. Nucleic Acids Res. 45, 2936 (2017).
42. Horn, F. et al. GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res. 26, 275-279 (1998).
43. Boc, A., Diallo, A. B. & Makarenkov, V. T-REX: a web server for inferring, validating and visualizing phylogenetic trees and networks. Nucleic Acids Res. 40, W573-W579 (2012).